Skip to main content

The rockefeller university

News & HighlightsNews
Displaying 140 of 2963 articles.
Rockefeller team finds flawed data in recent study relevant to coronavirus antiviral development
New research demonstrates that a previously published structure and mechanism for RNA capping at work in coronaviruses is incorrect, with potentially sweeping implications for the quest to develop drugs targeting these pathogens.
Novel method dramatically improves cryo-EM’s imaging capabilities
Researchers have devised a way to visualize molecules that are very rare, very small, or hard to produce naturally—including some viruses.
Svetlana Mojsov is elected to the National Academy of Sciences
Mojsov is a research associate professor whose research led to the development of drugs for obesity and diabetes.
Svetlana Mojsov honored with 2025 Breakthrough Prize
Mojsov is recognized for her discovery of the peptide hormone GLP-1, research that led to a new class of safe and highly effective drugs for type 2 diabetes as well as the treatment of obesity.
How solving a hepatitis B paradox opened the door to new therapies
A collaboration between Rockefeller, MSK, and Weill Cornell answers a longstanding mystery about the basic biology of the hepatitis B virus, while also proposing a novel therapy.
How fruit flies flit between courtship and aggression to fight for mates
Male fruit flies don’t just sing to their mates; they also use sound-cancelling wing-flicks to jockey with rivals. This new understanding of how male flies compete for female partners could shed light on how the brain balances cooperation and competition.
New mechanism for maintaining genome stability discovered
New research reveals how the RapA enzyme protects against R-loop cytotoxicity in E. coli.
A new class of antivirals could help prevent future pandemics
Researchers discovered a vulnerability in viral enzymes that could lead to novel treatments for diseases as diverse as COVID and Ebola, while also minimizing side effects and reducing the odds of drug resistance.
Why a promising breast cancer drug doesn’t work—and how to improve it
A treatment that appears effective in cancers such as myelofibrosis consistently fails in breast cancer clinical trials. A new study explains why.
This technique for studying cell receptors could have sweeping implications for drug development
Researchers created a tool capable of comprehensively mapping crucial interactions underlying drug efficacy in one superfamily of cell receptors.
View
View